Funding for this research was provided by:
Japan Society for the Promotion of Science (17K09533)
Suzuken Memorial Foundation (2013)
Received: 28 December 2019
Accepted: 10 May 2020
First Online: 15 May 2020
Ethics approval and consent to participate
: The study protocol was approved by the ethics committee of the Fujita Health University School of Medicine, approval number 14–031. Each participant provided written informed consent. In adults with cognitive decline, the guardians of these participants provided consent on their behalf.
: Not applicable.
: EW has received lecture fees from Biotronik Japan and Daiichi-Sankyo, MH has received lecture fees from Boehringer Ingelheim and Bristol Meyers Squibb. None of the other authors have any conflict of interest.